The Path to a Clear Diagnosis

Because Familial Non-Autoimmune Hyperthyroidism (FNAH) is so rare, the diagnostic process is often a process of elimination. Doctors usually begin by testing for common conditions and only move toward genetic testing when the “standard” explanations don’t fit your clinical picture.

The path to a diagnosis typically involves three main steps: blood work, imaging, and finally, molecular confirmation ^[1][2].

Step 1: Confirming the “Overdrive”

The first goal is to prove that your thyroid is actually overactive. This is done through standard thyroid function tests:

• TSH (Thyroid-Stimulating Hormone): In FNAH, this will usually be suppressed (very low or undetectable) because the brain is trying—unsuccessfully—to tell the thyroid to slow down ^[3].
• Free T4 and Free T3: These are the actual thyroid hormones. One or both will often be elevated ^[1][4]. However, in subclinical hyperthyroidism, these hormones may be in the normal range while TSH remains low.

Step 2: Looking for an Autoimmune Attack

To distinguish FNAH from Graves’ disease, doctors look for antibodies that indicate an immune system problem:

• TRAb and TSI: These tests (Thyroid Receptor Antibodies and Thyroid Stimulating Immunoglobulins) measure whether your immune system is attacking the thyroid. In FNAH, these tests usually come back negative ^[1][5].
• Interpretation Caution: A negative result is a strong clue but does not completely rule out Graves’ disease, as some people have “seronegative” disease where antibodies don’t show up ^[6]. It is important to look at your lab report’s specific “cut-off” values, as different labs use different reference ranges ^[7].

Step 3: Mapping the Thyroid

Your doctor may order imaging to see the gland’s anatomy and activity:

• Ultrasound: This uses sound waves to check the size and texture of the thyroid, helping identify nodules ^[5][8].
• Scintigraphy (Thyroid Scan): You are given a tiny amount of a radioactive tracer to see where the thyroid is active. While this helps assess function, it cannot confirm FNAH on its own. In FNAH, the scan may appear varied—sometimes showing diffuse uptake (which can closely mimic Graves’ disease) or appearing heterogeneous ^[9][5].

The Final Answer: Genetic Testing and Counseling

Finding an appropriately classified pathogenic or likely pathogenic activating variant through germline TSHR genetic testing strongly supports the diagnosis of FNAH in the right clinical context ^[10].

• What to Look For: The test looks for a “pathogenic” (disease-causing) variant in the TSHR gene ^[2].
• De Novo vs. Inherited: If a mutation is found, testing your parents can determine if it was inherited or if it is a “de novo” mutation (one that started with you) ^[11].
• Because variant interpretation is complex, a genetic counselor is highly recommended to help you understand the results and coordinate family testing.

Cascade Screening: Protecting Your Family

Once a mutation is confirmed in you, it opens the door for cascade testing ^[2]. This means your first-degree relatives (parents, siblings, and children) can meet with a genetic counselor to discuss targeted genetic testing to see if they carry the same variant.

This is vital because many people with the FNAH mutation are asymptomatic carriers—they may feel fine today, but their thyroid could switch into overdrive at any time ^[12]. Identifying them early allows for individualized, lifelong monitoring, ensuring they can be treated before serious complications occur ^[13].